(FM) Inmunología
Departamento académico
Beth Israel Deaconess Medical Center
Boston, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von Beth Israel Deaconess Medical Center (2)
2017
-
Results from an integrated safety analysis of urelumab, an agonist anti-CD137 monoclonal antibody
Clinical Cancer Research, Vol. 23, Núm. 8, pp. 1929-1936
2011
-
Defining the critical hurdles in cancer immunotherapy
Journal of Translational Medicine